How many studies have been conducted on Thiotepa?

BiohacksAI has indexed 298 PubMed studies on Thiotepa, including 15 randomized controlled trials (RCTs). 48% of studies involve human subjects.

What are the main research areas for Thiotepa?

The primary research domains for Thiotepa are 🔬 Oncology, 🧬 Hormones, 🫁 Liver & Detox. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thiotepa

A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

298+ PubMed studies analyzed · 15 RCTs · Evidence Score: 47.1

Research Domains

Thiotepa has been studied across 16 research domains including 🔬 Oncology, 🧬 Hormones, 🫁 Liver & Detox, ✨ Skin & Hair, 😴 Sleep. The primary research focus is 🔬 Oncology with 58% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thiotepa is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.